File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1080/14737159.2019.1656530
- Scopus: eid_2-s2.0-85070994160
- WOS: WOS:000482357300001
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: The applications of metabolomics in the molecular diagnostics of cancer
Title | The applications of metabolomics in the molecular diagnostics of cancer |
---|---|
Authors | |
Keywords | cancer metabolite profiling metabolomics molecular diagnostics MS |
Issue Date | 2019 |
Publisher | Taylor & Francis. The Journal's web site is located at http://www.tandfonline.com/loi/iero20#.VgGYxUaFOnI |
Citation | Expert Review of Molecular Diagnostics, 2019, v. 19 n. 9, p. 785-793 How to Cite? |
Abstract | Introduction: Metabolomics, the study of metabolites, is a promising research field for cancers. The metabolic pathway in a tumor cell is different from a normal tissue cell. There are two approaches to study the metabolism, targeted and untargeted. The general approach is that metabolomic data are interpreted by bioinformatics tools correlating with metabolomic databases to obtain significant findings. With the use of specific analysis tools, such as nuclear magnetic resonance (NMR) and mass spectrometer (MS) combined with chromatography, metabolic profile or metabolic fingerprint of various biological specimens could be obtained. The applications of metabolomics are used to discover potential cancer biomarkers and monitor the metastatic state, therapeutic and drug response for better patient management. Areas covered: In this review, the author introduce metabolomics and discuss the use of metabolomics approaches in different cancers, including the study of colorectal cancer, prostate cancer, liver cancer, pancreatic cancer and breast cancer using NMR and MS. Expert opinion: Knowledge on the molecular basis of cancer metabolism and its potential clinical applications has been improving recently. However, there are still many challenges for the technological development and integration of metabolomics with other omics spaces such as genomics. In the near future, it is expected that metabolomics will play an important role in cancer molecular diagnostics. © 2019, © 2019 Informa UK Limited, trading as Taylor & Francis Group. |
Persistent Identifier | http://hdl.handle.net/10722/275116 |
ISSN | 2023 Impact Factor: 3.9 2023 SCImago Journal Rankings: 0.823 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Cheung, PK | - |
dc.contributor.author | Ma, MH | - |
dc.contributor.author | Tse, HF | - |
dc.contributor.author | Yeung, HF | - |
dc.contributor.author | Chu, MKM | - |
dc.contributor.author | Kan, CM | - |
dc.contributor.author | Cho, WCS | - |
dc.contributor.author | Ng, LBW | - |
dc.contributor.author | Chan, LWC | - |
dc.contributor.author | Wong, SCC | - |
dc.date.accessioned | 2019-09-10T02:35:46Z | - |
dc.date.available | 2019-09-10T02:35:46Z | - |
dc.date.issued | 2019 | - |
dc.identifier.citation | Expert Review of Molecular Diagnostics, 2019, v. 19 n. 9, p. 785-793 | - |
dc.identifier.issn | 1473-7159 | - |
dc.identifier.uri | http://hdl.handle.net/10722/275116 | - |
dc.description.abstract | Introduction: Metabolomics, the study of metabolites, is a promising research field for cancers. The metabolic pathway in a tumor cell is different from a normal tissue cell. There are two approaches to study the metabolism, targeted and untargeted. The general approach is that metabolomic data are interpreted by bioinformatics tools correlating with metabolomic databases to obtain significant findings. With the use of specific analysis tools, such as nuclear magnetic resonance (NMR) and mass spectrometer (MS) combined with chromatography, metabolic profile or metabolic fingerprint of various biological specimens could be obtained. The applications of metabolomics are used to discover potential cancer biomarkers and monitor the metastatic state, therapeutic and drug response for better patient management. Areas covered: In this review, the author introduce metabolomics and discuss the use of metabolomics approaches in different cancers, including the study of colorectal cancer, prostate cancer, liver cancer, pancreatic cancer and breast cancer using NMR and MS. Expert opinion: Knowledge on the molecular basis of cancer metabolism and its potential clinical applications has been improving recently. However, there are still many challenges for the technological development and integration of metabolomics with other omics spaces such as genomics. In the near future, it is expected that metabolomics will play an important role in cancer molecular diagnostics. © 2019, © 2019 Informa UK Limited, trading as Taylor & Francis Group. | - |
dc.language | eng | - |
dc.publisher | Taylor & Francis. The Journal's web site is located at http://www.tandfonline.com/loi/iero20#.VgGYxUaFOnI | - |
dc.relation.ispartof | Expert Review of Molecular Diagnostics | - |
dc.rights | AOM/Preprint Before Accepted: his article has been accepted for publication in [JOURNAL TITLE], published by Taylor & Francis. AOM/Preprint After Accepted: This is an [original manuscript / preprint] of an article published by Taylor & Francis in [JOURNAL TITLE] on [date of publication], available online: http://www.tandfonline.com/[Article DOI]. Accepted Manuscript (AM) i.e. Postprint This is an Accepted Manuscript of an article published by Taylor & Francis in [JOURNAL TITLE] on [date of publication], available online: http://www.tandfonline.com/[Article DOI]. | - |
dc.subject | cancer | - |
dc.subject | metabolite profiling | - |
dc.subject | metabolomics | - |
dc.subject | molecular diagnostics | - |
dc.subject | MS | - |
dc.title | The applications of metabolomics in the molecular diagnostics of cancer | - |
dc.type | Article | - |
dc.identifier.email | Tse, HF: hftse@hkucc.hku.hk | - |
dc.identifier.authority | Tse, HF=rp00428 | - |
dc.description.nature | link_to_subscribed_fulltext | - |
dc.identifier.doi | 10.1080/14737159.2019.1656530 | - |
dc.identifier.scopus | eid_2-s2.0-85070994160 | - |
dc.identifier.hkuros | 304616 | - |
dc.identifier.volume | 19 | - |
dc.identifier.issue | 9 | - |
dc.identifier.spage | 785 | - |
dc.identifier.epage | 793 | - |
dc.identifier.isi | WOS:000482357300001 | - |
dc.publisher.place | United Kingdom | - |
dc.identifier.issnl | 1473-7159 | - |